Company / Income Tax per Share
CRISPR Therapeutics AG Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.04
FY2025
5-year range
-$0.00 / $0.04
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#54 of 201
Health Care
What the data says
At $0.04, CRISPR Therapeutics AG's income tax per share ranks #148 of 201 in the Health Care sector. Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.01 in FY2016 to $0.04 in FY2024.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of +28.2%.
Increased from $0.04 to $0.04 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +28.2%
- 10-Year CAGR
- -
Sector benchmark
#148 of 201 in Health CareTop 73% of 201This company $0.04 Sector average $1.35
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 9.4% year-over-year.
- Ranks #54 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2024.
- Lowest income tax per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | -9.4% |
| FY2024 | $0.04 | +16.0% |
| FY2023 | $0.04 | +971.6% |
| FY2022 | -$0.00 | -117.0% |
| FY2021 | $0.02 | +121.9% |
| FY2020 | $0.01 | +26.7% |
| FY2019 | $0.01 | -27.5% |
| FY2018 | $0.01 | +6665.6% |
| FY2017 | $0.00 | +101.5% |
| FY2016 | -$0.01 | -920.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026